side effects to glp 1 Your guide GLP-1 Peptide/GLP-1 Complications: 11 Hidden Risks

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

Prescriptions for patients below BMI 27 are automatically denied unless there's a documented endocrine disorder causing weight gain

162,163 Retatrutide (LY-3437943), a novel triple agonist developed by Eli Lilly that targets GLP-1R, GIPR and GCGR, has shown potential in preliminary clinical data for providing excellent blood sugar control and significant weight reduction

Small molecule drug discovery at the glucagon-like peptide-1 receptor

Commonly used GLP-1 receptor agonists: Ozempic (semaglutide) Rybelsus (semaglutide) Wegovy (semaglutide) Trulicity (dulaglutide) Victoza (liraglutide) Saxenda (liraglutide) Mounjaro (tirzepatide) Which GLP-1 is best for diabetes